NorthWater · Water

Fragmented, essential,
and under-consolidated.

Water treatment M&A across the United States — building scale in a market where scale is scarce and regulation is tightening.

Treatment and storage

Thesis

Regulation is forcing capital
into a fragmented market.

U.S. water and wastewater treatment is served by thousands of small operators, municipal systems, and family-owned service businesses. Very few have the balance sheet or the technical capability to absorb the compliance capex that tightening standards — PFAS chief among them — now require.

That combination is the classic consolidation setup: essential service, inelastic demand, regulatory-driven capex, and a seller base without access to institutional capital. The returns come from operational integration and procurement scale, not from financial engineering.

NorthWater pursues platform acquisitions and bolt-ons in treatment and treatment services, and advises owners of these businesses where the alternative is funding a compliance program alone.

Focus Areas

Where we focus.

Platforms

Buy-and-build in treatment

Acquiring a platform with credible management and real integration capacity, then building through disciplined bolt-ons rather than a single large bet.

Services

Recurring contracted revenue

O&M, monitoring, and specialty treatment businesses with contracted recurring revenue and regulatory-driven demand.

Compliance Capex

PFAS and emerging contaminants

Situations where a tightening standard creates a capital requirement the incumbent owner cannot fund alone — and where that requirement is the transaction.

Advisory

Owner-operators and families

Advising founders and families on process, valuation, and counterparty selection when the decision is to transact rather than to recapitalize.

Regulatory timelines, contract tenor, and customer concentration are diligenced explicitly. Compliance capex requirements are underwritten from the applicable standard rather than from seller estimates.

Selected Imagery